NEXGEL, Inc. (NXGL) intrinsic value & 10-year financials
NEXGEL, Inc. (NXGL) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 9 fiscal years revenue grew 26.4% a year to $11.4M, with an average return on invested capital of -252.0%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $5.59
- Market cap
- $43.9M
- Revenue (FY2025)
- $11.4M
- Revenue growth (9-yr CAGR)
- 26.4%
- ROIC (10-yr avg)
- -252.0%
- Free cash flow (FY2025)
- -$1.4M
NXGL 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $11.4M | -$3.0M | -$0.38 | -$1.4M | -29.3% | -45.0% |
| FY2024 | $8.7M | -$3.3M | -$0.50 | -$4.3M | -40.9% | -59.4% |
| FY2023 | $4.1M | -$3.2M | -$0.56 | -$3.9M | -85.0% | -48.7% |
| FY2022 | $2.0M | -$4.7M | -$0.85 | -$3.1M | -163.5% | -75.3% |
| FY2021 | $1.6M | -$4.3M | -$1.45 | -$3.0M | -165.7% | -460.6% |
| FY2020 | $674.0K | -$2.3M | -$0.03 | -$2.1M | -335.3% | -308.3% |
| FY2019 | $717.0K | -$1.9M | -$0.02 | -$1.8M | -268.3% | -346.7% |
| FY2018 | $2.2M | -$1.9M | -$0.06 | — | -85.3% | -671.9% |
| FY2017 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
NEXGEL, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
NEXGEL, INC. has historically struggled to out-earn its cost of capital, averaging just -30.8% ROIC.
NEXGEL, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, NEXGEL, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-12.62 per share.